Replies to post #381 on SurModics Inc (SRDX)

[DewDiligence]

>I disagree. For one, the STRIDE data are very good, IMHO…<

Our views of the I-vation data are probably closer than you think. All I meant was that the data are not the blowout result that might have caused InnoRx insiders and affiliates to hang on to their shares for a really big pop.

>…are you suggesting InnoRx insiders had access to data back in May/June?<

They may have—the trial was open-label.